Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11446382 Animal protein-free pharmaceutical compositions

Patent 11446382 was granted and assigned to Allergan, Inc. on September, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Terrence J. Hunt0

Date of Patent

September 20, 2022

0

Patent Application Number

171437700

Date Filed

January 7, 2021

0

Patent Citations

US Patent 10293034 Pharmaceutical liquid composition of botulinum toxin with improved stability and method of use

0

US Patent 10369190 Non-protein clostridial toxin compositions

US Patent 10465178 Process and system for obtaining botulinum neurotoxin

US Patent 10549042 Botulinum toxin prefilled glass syringe

US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose

US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins

0

US Patent 10744202 Sustained release eye drop formulations

US Patent 10946030 Formulations of deoxycholic acid and salts thereof

...

Patent Primary Examiner

Jennifer E. Graser

0

Animal protein-free, solid-form Clostridial toxin pharmaceutical compositions comprising a Clostridial toxin active ingredient and at least two excipients.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11446382 Animal protein-free pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool